The UAMS IRB has updated its convened board committee rosters, effective Feb. 6, 2026. We look forward to working with our new reviewers, and extend our thanks to those are continuing to serve and who have cycled off the board. We so appreciate your support of the UAMS Human Research Protection Program.
Research News
Investigators, study staff, research administrators — keep up with research happenings in our Research News and Tips blog. Reminders for working with the Institutional Review Board, Clinical Research Administration (CLARA) tips, educational opportunities — we’ll post all that, and more, on this blog.
Consent and HIPAA Auth. Form template updates
After consultation with Research Legal and the UAMS IRB Chair, language about costs related to research participation have been updated in the IRB’s informed consent template. There has also been a minor-looking but important change in the HIPAA authorization form language about how data might leave the institution if an investigator leaves UAMS before a […]
UAMS AI Policy
Artificial Intelligence tools’ use in clinical research settings is expected to grow. UAMS has an Academic Affairs Policy titled UAMS Artificial Intelligence Generative Tool Use Policy, accessible at this link. It is also available in Compliance360. Research-specific information about AI use begins at the bottom of page 4. We recommend checking this policy frequently as […]
New FDA Guidances
The federal Food and Drug Administration has been staying busy, posting new guidances, updates, and drafts since late 2025. Colleagues at HRP Consulting Group have posted a compilation of these new releases on their website. The following will be of particular interest to our research community: Final Guidance: Enhancing Participation in Clinical Trials – Eligibility […]
Reporting adverse events at CR
Studies required to submit full continuing review forms must include a list of adverse events (AEs) with their CR submissions. The IRB asks that in addition to including dates of occurrence of AEs, these reports reflect the outcome of the AE, such as “ongoing,” or “resolved.” If the date of resolution is known, please include […]
The continuing review study summary
Continuing review, for studies that require it, is an opportunity for the IRB to reevaluate the study in its entirety to ensure the criteria for approval remain met. The IRB needs complete information about what has happened on the study in the past review period to be able to thoroughly assess the study. We have […]
Additional review for some studies
The UAMS Research Legal Office has advised that some types of human subject research may not be allowable under recent federal and state requirements related to diversity, equity, and inclusion measures. These restrictions apply to both new studies and to those that are ongoing, per information provided by research legal. The following information was provided […]
Protocol template update
The IRB has an updated protocol template available on its website. The new template has added some new information and moved some previous language around. You’ll note that the new template has far more guidance than earlier iterations, and less suggested text. This change’s intent is to provide prompts to study teams to draft their […]
CITI courses updates
The CITI program includes several courses required for people involved with human subject research, animal research, or export control. Because CITI has recently changed its fee schedule, with charges accruing based on the number of course completions, the Division of Research and Innovation has started limiting access to the UAMS CITI courses. People whose email […]
Meet your research administrators
Get to know all the main players who support research efforts at the upcoming Research Administration Roundtable. The Division of Research and Innovation has scheduled this event for Sept. 2, from 1:30 to 2:30 pm. Come to the Rayford Auditorium in Biomed II to hear from the various departments that help you get funding and […]